DNA-minus temperature-sensitive mutants of adenovirus type 5 help adenovirus-associated virus replication.

PubWeight™: 1.54‹?› | Rank: Top 4%

🔗 View Article (PMC 515397)

Published in J Virol on January 01, 1975

Authors

S E Straus, H S Ginsberg, J A Rose

Articles citing this

Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J Virol (1996) 5.94

Concatemers of alternating plus and minus strands are intermediates in adenovirus-associated virus DNA synthesis. Proc Natl Acad Sci U S A (1976) 4.62

Latent infection of KB cells with adeno-associated virus type 2. J Virol (1986) 2.88

Partial purification of adeno-associated virus Rep78, Rep52, and Rep40 and their biochemical characterization. J Virol (1992) 2.84

Evidence for covalent attachment of the adeno-associated virus (AAV) rep protein to the ends of the AAV genome. J Virol (1990) 2.62

In vitro replication of adeno-associated virus DNA. J Virol (1994) 2.09

Locations of adenovirus genes required for the replication of adenovirus-associated virus. Proc Natl Acad Sci U S A (1981) 1.90

Effect of deletions in adenovirus early region 1 genes upon replication of adeno-associated virus. J Virol (1982) 1.76

Adenovirus helper function for growth of adeno-associated virus: effect of temperature-sensitive mutations in adenovirus early gene region 2. J Virol (1980) 1.54

The adeno-associated virus rep gene inhibits replication of an adeno-associated virus/simian virus 40 hybrid genome in cos-7 cells. J Virol (1988) 1.42

Vero cells injected with adenovirus type 2 mRNA produce authentic viral polypeptide patterns: early mRNA promotes growth of adenovirus-associated virus. Proc Natl Acad Sci U S A (1980) 1.23

In vitro replication of adeno-associated virus DNA: enhancement by extracts from adenovirus-infected HeLa cells. J Virol (1996) 1.18

Adeno-associated virus helper activity of adenovirus DNA binding protein. J Virol (1982) 1.14

Cloning and physical mapping of enteric adenoviruses (candidate types 40 and 41). J Virol (1984) 1.00

Purification of host cell enzymes involved in adeno-associated virus DNA replication. J Virol (2007) 0.96

Isolation of the viral DNA replication complex from adeno-associated virus type 1-infected cells. J Virol (1977) 0.86

HPV-16 E1, E2 and E6 each complement the Ad5 helper gene set, increasing rAAV2 and wt AAV2 production. Gene Ther (2011) 0.78

Articles cited by this

Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol (1967) 106.91

Studies of small DNA viruses found in various adenovirus preparations: physical, biological, and immunological characteristics. Proc Natl Acad Sci U S A (1966) 7.35

Selection and preliminary characterization of temperature-sensitive mutants of type 5 adenovirus. J Virol (1972) 4.96

Evidence for a single-stranded adenovirus-associated virus genome: isolation and separation of complementary single strands. J Virol (1970) 4.73

Adenovirus-2 DNA contains an inverted terminal repetition. Proc Natl Acad Sci U S A (1972) 4.57

A unique form of terminal redundancy in adenovirus DNA molecules. Proc Natl Acad Sci U S A (1972) 4.18

DNA-binding proteins specific for cells infected by adenovirus. Nat New Biol (1973) 3.30

Thermolabile DNA binding proteins from cells infected with a temperature-sensitive mutant of adenovrius defective in viral DNA synthesis. J Virol (1975) 3.29

Self-complementarity of terminal sequences within plus or minus strands of adenovirus-associated virus DNA. Proc Natl Acad Sci U S A (1973) 2.96

Adenovirus-associated virus multiplication. VII. Helper requirement for viral deoxyribonucleic acid and ribonucleic acid synthesis. J Virol (1972) 2.74

A quantitative assay for DNA-DNA hybrids using membrane filters. Biochem Biophys Res Commun (1966) 2.32

Adenovirus-associated virus multiplication. VI. Base compostion of the deoxyribonucleic acid strand species and strand-specific in vivo transcription. J Virol (1971) 2.05

Separate helper functions provided by adenovirus for adenovirus-associated virus multiplication. Nat New Biol (1973) 1.82

Genetic relatedness studies with adenovirus-associated viruses. J Virol (1968) 1.76

The role of herpesviruses in adenovirus-associated virus replication in vitro. Virology (1970) 1.70

Adenovirus-associated virus multiplication. 8. Analysis of in vivo transcription induced by complete or partial helper viruses. J Virol (1972) 1.65

Adenovirus-associated viruses: enhancement by human herpesviruses. Proc Soc Exp Biol Med (1970) 1.43

Characterization of temperature-sensitive mutants of adenovirus type 5--serology. J Gen Virol (1972) 1.39

Temperature-sensitive mutants of human adenovirus type 12. Virology (1971) 1.38

A temperature-sensitive mutant of adenovirus 31, defective in viral deoxyribonucleic acid replication. Virology (1971) 1.37

Nonencapsidated infectious DNA of adeno-satellite virus in cells coinfected with herpesvirus. Science (1971) 1.13

Temperature-sensitive mutants of adenovirus type 12 defective in viral DNA synthesis. J Virol (1974) 1.08

Analysis of adeno-associated satellite virus DNA. Biochim Biophys Acta (1973) 0.92

Adeno-associated satellite virus growth supported by a temperature-sensitive mutant of human adenovirus. J Gen Virol (1970) 0.91

Articles by these authors

The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med (1994) 26.24

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06

Chronic fatigue syndrome: a working case definition. Ann Intern Med (1988) 9.12

Finding and applying evidence during clinical rounds: the "evidence cart". JAMA (1998) 7.30

Measurement of serum DNA-binding activity in systemic lupus erythematosus. N Engl J Med (1969) 6.16

Evidence for a single-stranded adenovirus-associated virus genome: formation of a DNA density hybrid on release of viral DNA. Proc Natl Acad Sci U S A (1969) 5.78

Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest (1998) 5.70

Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell (1995) 5.64

Interventions to improve antibiotic prescribing practices in ambulatory care. Cochrane Database Syst Rev (2005) 5.48

Selection and preliminary characterization of temperature-sensitive mutants of type 5 adenovirus. J Virol (1972) 4.96

Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group. JAMA (1999) 4.91

Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses. Proc Natl Acad Sci U S A (1986) 4.89

Evidence for a single-stranded adenovirus-associated virus genome: isolation and separation of complementary single strands. J Virol (1970) 4.73

Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA (1999) 4.71

Concatemers of alternating plus and minus strands are intermediates in adenovirus-associated virus DNA synthesis. Proc Natl Acad Sci U S A (1976) 4.62

Latent herpes simplex virus in human trigeminal ganglia. Detection of an immediate early gene "anti-sense" transcript by in situ hybridization. N Engl J Med (1987) 4.57

Postherpetic neuralgia--pathogenesis, treatment, and prevention. N Engl J Med (1996) 4.36

A unique form of terminal redundancy in adenovirus DNA molecules. Proc Natl Acad Sci U S A (1972) 4.18

Intracellular uncoating of type 5 adenovirus deoxyribonucleic acid. J Virol (1967) 3.92

Herpes simplex virus types 1 and 2 completely help adenovirus-associated virus replication. J Virol (1981) 3.72

Nucleic acid from an adeno-associated virus: chemical and physical studies. Proc Natl Acad Sci U S A (1966) 3.55

Patterns of gene expression and sites of latency in human nerve ganglia are different for varicella-zoster and herpes simplex viruses. Proc Natl Acad Sci U S A (1988) 3.49

Personal health records: a scoping review. J Am Med Inform Assoc (2011) 3.41

Users' guides to the medical literature: XX. Integrating research evidence with the care of the individual patient. Evidence-Based Medicine Working Group. JAMA (2000) 3.33

Direct mapping of adeno-associated virus capsid proteins B and C: a possible ACG initiation codon. Proc Natl Acad Sci U S A (1985) 3.31

Thermolabile DNA binding proteins from cells infected with a temperature-sensitive mutant of adenovrius defective in viral DNA synthesis. J Virol (1975) 3.29

RNA production in adenovirus-infected KB cells. Virology (1965) 3.06

Adenovirus E1B proteins are required for accumulation of late viral mRNA and for effects on cellular mRNA translation and transport. Mol Cell Biol (1985) 3.04

Structural proteins of adenovirus-associated viruses. J Virol (1971) 3.03

Cell transformation: a study of regulation with types 5 and 12 adenovirus temperature-sensitive mutants. Cold Spring Harb Symp Quant Biol (1975) 3.01

Research into complementary and alternative medicine: problems and potential. BMJ (2001) 2.97

Self-complementarity of terminal sequences within plus or minus strands of adenovirus-associated virus DNA. Proc Natl Acad Sci U S A (1973) 2.96

Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial. JAMA (1998) 2.94

Regulation of the primary expression of the early adenovirus transcription units. J Virol (1979) 2.92

Nucleic acid homology studies of adenovirus type 7-SV40 interactions. Proc Natl Acad Sci U S A (1966) 2.86

Adenovirus type 5 early region 1b gene product is required for efficient shutoff of host protein synthesis. J Virol (1984) 2.82

Characterization of a Tumorlike Antigen in Type 12 and Type 18 Adenovirus-Infected Cells. J Bacteriol (1965) 2.80

Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell (1999) 2.74

Adenovirus-associated virus multiplication. VII. Helper requirement for viral deoxyribonucleic acid and ribonucleic acid synthesis. J Virol (1972) 2.74

Simian virus 40 integration site in an adenovirus 7-simian virus 40 hybrid DNA molecule. Proc Natl Acad Sci U S A (1971) 2.64

Varicella-zoster virus transcription in human trigeminal ganglia. Virology (1993) 2.63

A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N Engl J Med (1999) 2.62

Death in the AIDS patient: role of cytomegalovirus. N Engl J Med (1983) 2.61

Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses. J Med Virol (2001) 2.58

Inhibition of host protein synthesis in type 5 adenovirus-infected cells. J Virol (1967) 2.50

Synthesis of virus-specific ribonucleic acid in KB cells infected with type 2 adenovirus. J Virol (1971) 2.48

Why we need large, simple studies of the clinical examination: the problem and a proposed solution. CARE-COAD1 group. Clinical Assessment of the Reliability of the Examination-Chronic Obstructive Airways Disease Group. Lancet (1999) 2.47

Mechanism by which fiber antigen inhibits multiplication of type 5 adenovirus. J Virol (1967) 2.44

Structure of varicella-zoster virus DNA. J Virol (1981) 2.43

Psychiatric diagnoses in patients who have chronic fatigue syndrome. J Clin Psychiatry (1989) 2.42

Characterization of adenovirus-associated virus-induced polypeptides in KB cells. J Virol (1978) 2.40

Transformation properties of type 5 adenovirus mutants that differentially express the E1A gene products. Proc Natl Acad Sci U S A (1984) 2.39

Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial. JAMA (2001) 2.38

Analysis of type 5 adenovirus transformation with a cloned rat embryo cell line (CREF). Proc Natl Acad Sci U S A (1982) 2.36

New enzyme immunoassays for measurement of influenza A/Victoria/3/75 virus in nasal washes. Lancet (1980) 2.35

Biochemical consequences of type 2 adenovirus and Simian virus 40 double infections of African green monkey kidney cells. J Virol (1970) 2.32

Suppression of frequently recurring genital herpes. A placebo-controlled double-blind trial of oral acyclovir. N Engl J Med (1984) 2.26

Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann Intern Med (1985) 2.25

Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine. J Infect Dis (2008) 2.25

Quantitation of latent varicella-zoster virus and herpes simplex virus genomes in human trigeminal ganglia. J Virol (1999) 2.25

Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab (1991) 2.23

Pathogenesis of adenovirus type 5 pneumonia in cotton rats (Sigmodon hispidus). J Virol (1993) 2.20

Propagation and in vitro studies of previously non-cultivable enteral adenoviruses in 293 cells. Lancet (1981) 2.18

Evidence based treatment of hypertension. Measurement of blood pressure: an evidence based review. BMJ (2001) 2.15

A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease. J Clin Invest (1992) 2.13

Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease. Nat Med (1999) 2.11

Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood (1997) 2.10

Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome. Blood (2000) 2.09

Varicella-zoster virus open reading frame 61 protein is functionally homologous to herpes simplex virus type 1 ICP0. J Virol (1992) 2.09

Adenovirus-associated virus multiplication. VI. Base compostion of the deoxyribonucleic acid strand species and strand-specific in vivo transcription. J Virol (1971) 2.05

Nasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo-controlled trial of intravenous zanamivir treatment. J Infect Dis (1999) 2.03

Genetic relatedness among mycoplasmas as determined by nucleic acid homology. J Bacteriol (1966) 2.00

Acute infectious mononucleosis. CD30 (Ki-1) antigen expression and histologic correlations. Am J Clin Pathol (1990) 1.99

Detection and preliminary characterization of herpes simplex virus type 1 transcripts in latently infected human trigeminal ganglia. J Virol (1988) 1.92

Locations of adenovirus genes required for the replication of adenovirus-associated virus. Proc Natl Acad Sci U S A (1981) 1.90

Synthesis of adeno-associated virus structural proteins requires both alternative mRNA splicing and alternative initiations from a single transcript. J Virol (1988) 1.89

Adenovirus-associated virus multiplication. IX. Extent of transcription of the viral genome in vivo. J Virol (1972) 1.87

Treating acute stroke patients with intravenous tPA. The OSF stroke network experience. Stroke (2000) 1.87

A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats. J Virol (1994) 1.86

Evidence based management of hypertension. Cardiovascular risk factors and their effects on the decision to treat hypertension: evidence based review. BMJ (2001) 1.85

Propagation and purification of high-titer human cytomegalovirus. Appl Microbiol (1971) 1.85

The medical review article revisited: has the science improved? Ann Intern Med (1999) 1.84

Adeno-associated virus proteins: origin of the capsid components. J Virol (1984) 1.84

Deletion of the E4 region of the genome produces adenovirus DNA concatemers. Proc Natl Acad Sci U S A (1994) 1.84

Separate helper functions provided by adenovirus for adenovirus-associated virus multiplication. Nat New Biol (1973) 1.82

Cytoplasmic synthesis of type 5 adenovirus capsid proteins. Proc Natl Acad Sci U S A (1968) 1.81

Cell lines containing varicella-zoster virus open reading frame 62 and expressing the "IE" 175 protein complement ICP4 mutants of herpes simplex virus type 1. J Virol (1988) 1.78

Genetic relatedness studies with adenovirus-associated viruses. J Virol (1968) 1.76

Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance. Am J Hum Genet (1999) 1.74

Varicella-zoster virus open reading frame 10 protein, the herpes simplex virus VP16 homolog, transactivates herpesvirus immediate-early gene promoters. J Virol (1993) 1.71

Mapping of base sequence heterologies between genomes from different adenovirus serotypes. Virology (1973) 1.71

The comparative effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in mice. J Infect Dis (1999) 1.70

Varicella-zoster virus (VZV) virion-associated transactivator open reading frame 62 protein enhances the infectivity of VZV DNA. Virology (1994) 1.70

Synthesis, transport, and morphogenesis of type adenovirus capsid proteins. J Virol (1970) 1.67

HIV-1 directly kills CD4+ T cells by a Fas-independent mechanism. J Exp Med (1998) 1.66

A proposed terminology for the adenovirus antigens and virion morphological subunits. Virology (1966) 1.66

Metabolism of mRNA from the transforming region of adenovirus 2. Cold Spring Harb Symp Quant Biol (1980) 1.66

Adenovirus-associated virus multiplication. 8. Analysis of in vivo transcription induced by complete or partial helper viruses. J Virol (1972) 1.65

Varicella-zoster virus complements herpes simplex virus type 1 temperature-sensitive mutants. J Virol (1987) 1.64